Get started
Keyword

melphalan

Description: An alkylating chemotherapy drug used to treat cancers and as conditioning therapy before stem cell transplantation.
Wikidata ID: wiki/Q2298283
OpenAlex ID: keywords/melphalan
Multiple myeloma
2000 · Noopur Raje, Kenneth C. Anderson · Current Treatment Options in Oncology · 2,163
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
2008 · Jesús F. San Miguel, Rudolf Schlag, et al. · New England Journal of Medicine · 1,901
PDF
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial
2002 · Norbert Schmitz, Beate Pfistner, et al. · The Lancet · 1,142
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
1997 · Sergio Giralt, Elihu Estey, et al. · Blood · 1,138
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
2017 · María-Victoria Mateos, Meletios A. Dimopoulos, et al. · New England Journal of Medicine · 989
PDF
Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research
2009 · Sergio Giralt, Karen Ballen, et al. · Transplantation and Cellular Therapy · 902
PDF
Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines
1999 · Jason S. Damiano, Anne E. Cress, et al. · Blood · 901
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
2000 · Teru Hideshima, Dharminder Chauhan, et al. · Blood · 876
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial
2007 · Thierry Facon, Jean Yves Mary, et al. · The Lancet · 869
Uveal melanoma
2020 · Martine J. Jager, Carol L. Shields, et al. · Nature Reviews Disease Primers · 825
POEMS syndrome: definitions and long-term outcome
2003 · Angela Dispenzieri, Robert A. Kyle, et al. · Blood · 820
PDF
Updated clinical practice guidelines for the prevention and treatment of mucositis
2007 · Dorothy M. Keefe, Mark M. Schubert, et al. · Cancer · 785
L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast Cancer
1975 · Bernard Fisher, Paul Carbone, et al. · New England Journal of Medicine · 741
Granulocyte-macrophage Colony-stimulating Factor to Harvest Circulating Haemopoietic Stem Cells for Autotransplantation
1989 · AlessandroM. Gianni, Marco Bregni, et al. · The Lancet · 740
Effect of Granulocyte Colony Stimulating Factor on Neutropenia Induced by Cytotoxic Chemotherapy
1988 · G. Morstyn, J. Keech, et al. · The Lancet · 723
High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
1992 · D Lienard, P Ewalenko, et al. · Journal of Clinical Oncology · 719
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications
2003 · Nicholas Mitsiades, Constantine S. Mitsiades, et al. · Blood · 697
A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and Colchicine
1997 · Robert A. Kyle, Morie A. Gertz, et al. · New England Journal of Medicine · 688
PDF
erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer
1998 · Soonmyung Paik, John Bryant, et al. · JNCI Journal of the National Cancer Institute · 650
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
2015 · Alfred L. Garfall, Marcela V. Maus, et al. · New England Journal of Medicine · 624
PDF
Amyloidosis (AL). Clinical and laboratory features in 229 cases.
1983 · R A Kyle, P R Greipp · PubMed · 610
Overexpression of Metallothionein Confers Resistance to Anticancer Drugs
1988 · Susan L. Kelley, Alakananda Basu, et al. · Science · 601
Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients
1988 · U Duhrsen, JL Villeval, et al. · Blood · 584
PDF
Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer
1990 · Robert C. Young, Leslie A. Walton, et al. · New England Journal of Medicine · 583
PDF
Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
2001 · Sergio Giralt, Peter F. Thall, et al. · Blood · 574
Works count: 11,430
Citation count: 243,000
Year
Topic
Type